December 2019

November 2019

DarioHealth® Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes

By |2019-11-21T14:38:02+00:00November 15th, 2019|Blog|

DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting ("DTM") conference in Bethesda, Maryland, which showed remarkable improvements in average blood glucose [...]

October 2019

Cognoa Launches Pivotal Study of Diagnostic Aid for Autism

By |2019-11-21T15:08:43+00:00October 25th, 2019|Blog|

Cognoa, a Palo Alto, CA-based pediatric behavioral health company developing digital medicines, announced the launch of a pivotal study of its digital diagnostic aid for autism. The results of this pivotal study will be the basis for the submission to FDA next year. Study of [...]

Load More Posts